Clinic
Baytown Medical Center, LP
Baytown Medical Center, LP was paid $3.96M by Medicaid between May 2020 and Nov 2024, across 33 billing codes. Its largest line is 99284, emergency room visit (serious) — 37% of everything it billed.
33Billing provider infoBAYTOWN MEDICAL CENTER, LP
BAYTOWN, TX 77521
BAYTOWN, TX 77521
33aNPI1457820995assigned 11/14/2018
33bProvider typeAmbulatory Surgical Clinic/Center
28Total paid$3.96M
24GClaims62,054
24DCodes billed33
24AFirst – last monthMay 2020 – Nov 2024
Compared with peers
Next to other Ambulatory Surgical Clinic/Center providers in Texas
Rank by total paid#92 of 320
Median peer was paid$205K
This provider vs. median19×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 4,781 | $220K | |
| 2021 | 32,178 | $1.95M | |
| 2022 | 24,447 | $1.74M | |
| 2023 | 571 | $46K | |
| 2024incomplete | 77 | $3K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 37% | 2,219 | 2,130 | $1.45M |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 25% | 13,992 | 12,526 | $1.00M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 20% | 16,243 | 15,729 | $791K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 6.2% | 7,184 | 6,825 | $245K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 5.0% | 4,283 | 3,474 | $197K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.5% | 5,038 | 2,435 | $61K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 1.4% | 85 | 81 | $54K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 2,743 | 2,663 | $34K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 944 | 831 | $34K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 481 | 474 | $23K |
| 99072 | <1% | 2,862 | 2,211 | $20K | |
| 87807 | <1% | 854 | 831 | $13K |
21 more codes
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 314 | $7K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 217 | $6K |
| 80053 | Comprehensive metabolic panel | <1% | 232 | $4K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 565 | $3K |
| 86328 | <1% | 61 | $3K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 119 | $3K |
| 99001 | <1% | 298 | $2K | |
| A9150 | Non-prescription drugs | <1% | 495 | $2K |
| 81003 | <1% | 834 | $1K | |
| 81025 | <1% | 216 | $1K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 14 | $786.03 |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 12 | $657.93 |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 301 | $318.79 |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 43 | $314.17 |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 128 | $175.53 |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | <1% | 1,105 | $80.87 |
| 0240U | 0% | 69 | $0.00 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 29 | $0.00 |
| J3490 | Unclassified drugs | 0% | 15 | $0.00 |
| J8540 | Dexamethasone, oral, 0.25 mg | 0% | 16 | $0.00 |
| S0119 | Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) | 0% | 43 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialKAUR, JAGAN (CFO)
| Provider | Location | Paid |
|---|---|---|
| West Chase Houston Hospital | Houston, TX | $382K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.